Claraphi Advisory Network’s GSK GSK Stock Holding History

Claraphi Advisory Network’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-360	Closed	-$17K	–	654
2020 Q1	$17K	Sell	360 -5,440	-94%	-$290K	0.01%	671
2019 Q4	$341K	Sell	5,800 -240	-4%	-$13.3K	0.21%	116
2019 Q3	$322K	Sell	6,040 -209	-3%	-$10.8K	0.2%	121
2019 Q2	$313K	Buy	6,249 +569	+10%	+$28.6K	0.18%	140
2019 Q1	$297K	Hold	5,680	–	–	0.19%	145
2018 Q4	$271K	Hold	5,680	–	–	0.21%	134
2018 Q3	$285K	Sell	5,680 -3,290	-37%	-$167K	0.16%	180
2018 Q2	$452K	Buy	8,970 +3,049	+51%	+$154K	0.29%	90
2018 Q1	$289K	Sell	5,921 -40	-0.7%	-$1.86K	0.2%	151
2017 Q4	$264K	Buy	+5,961	New	+$275K	0.2%	155

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Claraphi Advisory Network's GSK Position: Q2 2020 in Review

Claraphi Advisory Network sold out of GSK (GSK) in Q2 2020, closing a stake of 360 shares — an estimated $17K sold.

Claraphi Advisory Network first reported a position in GSK in Q4 2017 and held it in 10 quarters. The position peaked at $452K in Q2 2018. 840 funds tracked by Wall St. Rank hold GSK as of Q2 2020.

Claraphi Advisory Network reported no remaining GSK position as of Q2 2020 after selling out during the quarter.
Claraphi Advisory Network sold 360 GSK shares in Q2 2020, an estimated $17K.
Claraphi Advisory Network first reported a position in GSK in Q4 2017 and held it in 10 quarters.
Claraphi Advisory Network's GSK position peaked at $452K in Q2 2018.
840 funds tracked by Wall St. Rank held GSK as of Q2 2020.

Based on Claraphi Advisory Network's 13F filing for Q2 2020, filed 14 Aug 2020.